Healthcare -
Biotechnology - NASDAQ - BM
$ 21.98
8.38 %
$ 1.6 B
Market Cap
-36.63
P/E
KNSA - SHORT-TERM INVESTMENTS
Short-term Investments KNSA - Kiniksa Pharmaceuticals, Ltd.
98.4 M
LAST VALUE
28.36%
2 YEAR CAGR
-16.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR